Analyst Ratings for Acadia Pharmaceuticals (ACAD) [Sells]
ACAD Rating Summary
ACAD Price Target Summary
- Highest: $19.00 (Piper Jaffray)
- Lowest: $3.00 (Roth Capital)
- Average: $12.40
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.40 (-10.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|
